Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening

BACKGROUND: There is limited understanding of the health economic implications of cervical screening with human papillomavirus (HPV)-16/18 genotyping. OBJECTIVE: The aim of this study was to evaluate the cost effectiveness of cervical cancer primary screening with a HPV-16/18 genotyping test which s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huh, Warner K., Williams, Erin, Huang, Joice, Bramley, Tommy, Poulios, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031721/
https://www.ncbi.nlm.nih.gov/pubmed/25385310
http://dx.doi.org/10.1007/s40258-014-0135-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031721/
https://www.ncbi.nlm.nih.gov/pubmed/25385310
http://dx.doi.org/10.1007/s40258-014-0135-4

Ejemplares similares